A Study of Anti-BCMA CAR-T Therapy in Newly Diagnosed Myeloma Patients Who Are Transplant-ineligible
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
CAR-T vs. Auto-SCT: Which Works Better for New Myeloma Patients?
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Risk-adapted Therapeutic Strategy in +1q NDMM
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Fall Risk Assessment and an Exercise Intervention for Prevention of Falls in Multiple Myeloma Patients
- Status
- RECRUITING
- Phase
- NA
Gustabor Phase 1 - AI-based Creation of a Nutritional Plan to Compensate for Chemotherapy-induced Taste Disorders
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Sequential CAR-T Cells Targeting BCMA/GPRC5D in Patients With Relapsed/ Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study to Assess Safety of Teclistamab in Indian Participants With Relapsed and Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE4
Long-term Follow-up Registry Study of Equecabtagene Autoleucel Injection
- Status
- RECRUITING
- Phase
- N/A
A Study on the Use of Sulpegfilgrastim to Prevent the Incidence of Neutropenia With Infection in Newly Diagnosed Non-transplant Multiple Myeloma Patients
- Status
- NOT_YET_RECRUITING
- Phase
- NA
The Efficacy and Safety of the Combination Therapy of Daratumumab, Cabozantinib, Pomalidomide, and Dexamethasone (D-KPd) in the Treatment of High-risk First-time Relapsed or Primary Refractory MM Patients
- Status
- NOT_YET_RECRUITING
- Phase
- NA
BCMA Bispecific Antibody Therapy for Post-BCMA CAR T-Cell Therapy Relapse (RECLAIM)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study to Evaluate CG-105-12 in Patients With Relapsed/Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
ERd Combination Treatment in Newly Diagnosed Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE2
Engaging T-cells to Eliminate MRD in Newly Diagnosed Myeloma Optimizing Response With Talquetmab and Teclistamab (ROTATE)
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Determine the Recommended Dose and Schedule, and Evaluate the Safety and Preliminary Efficacy of Mezigdomide in Combination With Elranatamab in Participants With Relapsed and/or Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE3
Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia
- Status
- RECRUITING
- Phase
- PHASE2
A Clinical Study of Allogeneic CD19/BCMA CAR-T Cells for the Treatment of R/R B-cell Malignant Tumors
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Mosaic Trial for Stem Cell Transplant Recipients
- Status
- RECRUITING
- Phase
- NA
All Japanese Population: Belantamab Mafodotin Plus Pomalidomide and Dexamethasone (Pd) Versus Bortezomib Plus Pd in Relapsed/Refractory Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3